An estimation of the population survival benefit of first-course chemotherapy and immunotherapy for leukemia

被引：0
|
作者：
Do, V. [1 ]
Jacob, S. [2 ]
Ng, W. [2 ]
Delaney, G. P. [2 ]
Barton, M. B. [2 ]
机构：
[1] Crown Princess Mary Canc Ctr, SWRON, Westmead, NSW, Australia
[2] Univ New South Wales, Ingham Inst Appl Med Res, Collaborat Canc Outcomes Res & Evaluat CCORE, Liverpool, NSW, Australia
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
346P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] An estimation of the population survival benefit of first-course chemotherapy for head and neck cancers
    Do, V.
    Ng, W.
    Jacob, S.
    Delaney, G. P.
    Barton, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] An estimation of the population-based survival benefit of first-course chemotherapy for advanced incurable cancer
    Do, V.
    Ng, W.
    Jacob, S.
    Delaney, G.
    Barton, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [3] An estimation of the population survival benefit of first-line chemotherapy and immunotherapy for breast cancer
    Delaney, G. P.
    Do, V.
    Ng, W.
    Barton, M. B.
    CANCER RESEARCH, 2017, 77
  • [4] AN ESTIMATION OF THE POPULATION SURVIVAL BENEFIT OF FIRST-LINE CHEMOTHERAPY FOR UPPER GASTROINTESTINAL CANCER
    Viet Do
    Weng Ng
    Delaney, Geoff P.
    Barton, Michael B.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 148 - 148
  • [5] An estimation of population-based survival benefit of first-line chemotherapy for urological cancer
    Do, V.
    Ng, W.
    Jacob, S.
    Delaney, G.
    Barton, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S510 - S510
  • [6] AN EVIDENCED-BASED ESTIMATION OF THE POPULATION SURVIVAL BENEFIT OF FIRST-LINE CHEMOTHERAPY FOR GYNAECOLOGICAL CANCER.
    Do, V.
    Ng, W.
    Delaney, G. P.
    Barton, M. B.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 192 - 193
  • [7] A Population-Based Observational Study of First-Course Treatment and Survival for Adolescent and Young Adult Females with Breast Cancer
    DeRouen, Mindy C.
    Gomez, Scarlett L.
    Press, David J.
    Tao, Li
    Kurian, Allison W.
    Keegan, Theresa H. M.
    JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2013, 2 (03) : 95 - 103
  • [8] An estimation of the population-based survival benefit of first-line chemotherapy for adult primary malignant brain tumour
    Do, V.
    Jacob, S.
    Ng, W.
    Delaney, G. P.
    Barton, M. B.
    ANNALS OF ONCOLOGY, 2015, 26 : 34 - 35
  • [9] CMF-regimen Preferred as First-course Chemotherapy for Older and Sicker Women With Breast Cancer Findings From a SEER-Medicare-based Population Study
    Kadakia, Aditi
    Rajan, Suja S.
    Abughosh, Susan
    Du, Xianglin L.
    Johnson, Michael L.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (02): : 165 - 173
  • [10] Immunotherapy Is Associated with a Survival Benefit in Patients Receiving Chemotherapy for Metastatic Pancreatic Cancer
    Hue, Jonathan J.
    Bingmer, Katherine
    Sugumar, Kavin
    Markt, Sarah C.
    Rothermel, Luke D.
    Hardacre, Jeffrey M.
    Ammori, John B.
    Winter, Jordan M.
    Ocuin, Lee M.
    JOURNAL OF PANCREATIC CANCER, 2021, 7 (01) : 31 - 38
12345